Initial Management of Colitis

Treatment Approach

The European Crohn’s and Colitis Organisation recommends a combination of topical mesalazine 1 g/day with oral mesalazine ≥ 2.4 g/day for initial management, which is more effective than either treatment alone for controlling inflammation and symptoms 1, 2
Combination therapy with topical mesalazine (≥ 1 g/day) plus oral mesalazine (≥ 2.4 g/day) is the most effective first-line approach for mild to moderate distal/left-sided colitis 1, 3
The American Gastroenterological Association suggests that once-daily dosing with mesalazine is as effective as divided doses and may improve adherence 1, 3
Topical mesalazine is more effective than topical corticosteroids and should be preferred for mild to moderate distal/left-sided colitis 1, 2

Oral prednisolone 40 mg daily is appropriate when prompt response is required or mesalazine has been unsuccessful, according to the National Institute for Health and Care Excellence 4, 2
Budesonide MMX 9 mg/day may be an alternative to conventional steroids in patients with left-sided disease who have inadequate response to 5-ASA, as recommended by the European Crohn’s and Colitis Organisation 1
Long-term steroid use should be avoided; rapid tapering is associated with early relapse, as stated by the American College of Gastroenterology 4, 2

Hospitalization is required for severe ulcerative colitis, and treatment involves intravenous steroids, fluid and electrolyte replacement, and close monitoring, according to the British Society of Gastroenterology 4
Joint management by a gastroenterologist and colorectal surgeon is essential for severe colitis, as recommended by the American Society of Colon and Rectal Surgeons 6
Patients should be informed about a 25-30% chance of needing colectomy, as stated by the European Crohn’s and Colitis Organisation 6

Always exclude infectious causes before attributing symptoms to IBD flare, as recommended by the Centers for Disease Control and Prevention 2
Combination therapy (topical plus oral) is more effective than either treatment alone, according to the American Gastroenterological Association 1, 3, 2
Maintenance therapy should be continued after remission is achieved to prevent relapse, as stated by the National Institute for Health and Care Excellence 6
Lifelong maintenance therapy is generally recommended, especially for those with left-sided or extensive disease, according to the European Crohn’s and Colitis Organisation 6